Clozapine-related EEG changes and seizures: Dose and plasma-level relationships

Therapeutic Advances in Psychopharmacology

Volumn 1, Issue 2, 2011, Pages 47-66

  Varma, Seema ^a   Bishara, Delia ^a   Besag, Frank M C ^b   Taylor, David ^c  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b SEPT: South Essex Partnership NHS Trust ^*  (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

antiepileptic; clozapine; seizure; valproate

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; ERYTHROMYCIN; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TOPIRAMATE; VALPROIC ACID; VALPROMIDE;

ADD ON THERAPY; AGRANULCOYTOSIS; AGRANULOCYTOSIS; ANEMIA; ANXIETY DISORDER; APPETITE; ASIAN; BONE MARROW SUPPRESSION; CLINICAL EVALUATION; DEPRESSION; DROP ATTACK; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG METABOLISM; DRUG WITHDRAWAL; DYSPEPSIA; EEG ABNORMALITY; EPILEPTIC DISCHARGE; GRANULOCYTOSIS; HAIR LOSS; HUMAN; LEUKOPENIA; LINEAR REGRESSION ANALYSIS; LOW DRUG DOSE; MEDICAL LITERATURE; MOOD DISORDER; MYOCLONUS SEIZURE; NAUSEA; NEUROTOXICITY; PANCYTOPENIA; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; SMOKING; SPEECH DISORDER; STATISTICAL SIGNIFICANCE; STOMACH IRRITATION; STUTTERING; TENDON REFLEX; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; WEIGHT GAIN;

EID: 84997941905     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125311405566     Document Type: Review

References (98)

1. Alarcon G. Nashef L. Cross H. Nightingale J. Richardson S. (2009) Epilepsy (Oxford Specialist Handbooks in Neurology), Oxford: Oxford University Press.
2. Antelo R.E. Stanilla J.K. Martin-Llonch N. (1994) Myoclonic seizures and “leg folding” phenomena with clozapine therapy: report of two cases. Biol Psychiatry 36: 759–762.
3. Atkinson J.M. Douglas-Hall P. Fischetti C. Sparshatt A. Taylor D.M. (2007) Outcome following clozapine discontinuation: a retrospective analysis. J Clin Psychiatry 68: 1027–1030.
4. Baker R.W. Conley R.R. (1991) Seizures during clozapine therapy. Am J Psychiatry 148: 1265–1266.
5. Balen R.M. Procyshyn R.M. (1999) Valproic acid for seizure prophylaxis during clozapine therapy: where's the evidence? Int J Psychiatry Clin Pract 3: 249–251.
6. Begum M. (2005) Clozapine-induced stuttering, facial tics and myoclonic seizures: a case report. Aust NZ J Psychiatry 39: 202–202.
7. Berman H. Zalma A. DuRand C.J. Green A.I. (1992) Clozapine-induced myoclonic jerks and drop attacks. J Clin Psychiatry 53: 329–330.
8. Boachie A. McGinnity M.G.A. (1997) Use of clozapine in a mental handicap hospital-report of the first 17 patients. Ir J Psychol Med 14: 16–19.
9. Bowden C.L. Calabrese J.R. Sachs G. Yatham L.N. Asghar S.A. Hompland M. et al. (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60: 392–400.
10. British Medical Association (2010) British National Formulary, 59th edn, London: BMJ Group and Pharmaceutical Press.
11. Brodtkorb E. Mula M. (2006) Optimizing therapy of seizures in adult patients with psychiatric comorbidity. Neurology 67(Suppl. 4): S39–S44.
12. Centorrino F. Baldessarini R.J. Kando J. Frankenburg F.R. Volpicelli S.A. Puopolo P.R. et al. (1994) Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 151: 123–125.
13. Chung S.J. Jeong S.H. Ahn Y.M. Kang U.G. Koo Y.J. Ha J.H. et al. (2002) A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 26: 139–144.
14. Conca A. Beraus W. Konig P. Waschgler R. (2000) A case of pharmacokinetic interference in comedication of clozapine and valproic acid. Pharmacopsychiatry 33: 234–235.
15. Cunnington M. Tennis P. (2005) Lamotrigine and the risk of malformations in pregnancy. Neurology 64: 955–960.
16. de Haan G.J. Edelbroek P. Segers J. Engelsman M. Lindhout D. Devile-Notschaele M. et al. (2004) Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 63: 571–573.
17. Devinsky O. Honigfeld G. Patin J. (1991) Clozapine-related seizures. Neurology 41: 369–371.
18. Devinsky O. Pacia S.V. (1994) Seizures during clozapine therapy. J Clin Psychiatry 55(Suppl. B): 153–156.
19. Dhar R. Singh T. Charvan B.S. (2008) Clozapine-induced drop-attack and myoclonus. German J Psychiatry 11: 29–31.
20. Duggal H.S. Jagadheesan K. Nizamie S.H. (2002) Clozapine-induced stuttering and seizures. Am J Psychiatry 159: 315–315.
21. DuMortier G. Mahe V. Pons D. Zerrouk A. Januel D. DeGrassat K. (2001) Clonic seizure associated with high clozapine plasma level. J Neuropsychiatry Clin Neurosci 13: 302–303.
22. Dursun S.M. Devarajan S. (2000) Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry 45: 198–198.
23. Dursun S.M. McIntosh D. Milliken H. (1999) Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry 56: 950–950.
24. Englisch S. Esser A. Enning F. Hohmann S. Schanz H. Zink M. (2010) Augmentation with pregabalin in schizophrenia. J Clin Psychopharmacol 30: 437–440.
25. Facciola G. Avenoso A. Scordo M.G. Madia A.G. Ventimiglia A. Perucca E. et al. (1999) Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit 21: 341–345.
26. Foster R. Olajide D. (2005) A case of clozapine-induced tonic-clonic seizures managed with valproate: implications for clinical care. J Psychopharmacol 19: 93–96.
27. Freudenreich O. Weiner R.D. McEvoy J.P. (1997) Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 42: 132–137.
28. Funderburg L.G. Vertrees J.E. True J.E. Miller A.L. (1994) Seizure following addition of erythromycin to clozapine treatment. Am J Psychiatry 151: 1840–1841.
29. Gandelman-Marton R. Theitler J. Klein C. Rabey J.M. (2008) Phenytoin intoxication in a clozapine-related prolonged seizure. J Emerg Med 35: 407–409.
30. Geddes J.R. Calabrese J.R. Goodwin G.M. (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194: 4–9.
31. Gouzoulis E. Grunze H. von B.U. (1991) Myoclonic epileptic seizures during clozapine treatment: a report of three cases. Eur Arch Psychiatry Clin Neurosci 240: 370–372.
32. Gouzoulis E. Ozdaglar A. Kasper J. (1993) Myoclonic seizures followed by grand mal seizures during clozapine treatment. Am J Psychiatry 150: 1128a–1128a.
33. Greenwood-Smith C. Lubman D.I. Castle D.J. (2003) Serum clozapine levels: a review of their clinical utility. J Psychopharmacol 17: 234–238.
34. Gunther W. Baghai T. Naber D. Spatz R. Hippins H. (1993) EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients. Pharmacopsychiatry 26: 69–74.
35. Haberfellner E.M. (2002) Myoclonic and generalized tonic clonic seizures during combined treatment with low doses of clozapine and haloperidol. Eur Psychiatry 17: 55–55.
36. Haddad P.M. Sharma S.G. (2007) Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 21: 911–936.
37. Hallahan B.P. Murray I.T. Doyle P.G. (2007) Clozapine induced stuttering. Ir J Psychol Med 24: 121–121.
38. Haller E. Binder R.L. (1990) Clozapine and seizures. Am J Psychiatry 147: 1069–1071.
39. Haring C. Neudorfer C. Schwitzer J. Hummer M. Saria A. Hinterhuber H. et al. (1994) EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology 114: 97–100.
40. Hofer A. Fleischhacker W.W. Hummer M. (2003) Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient. J Clin Psychiatry 64: 1267–1268.
41. Holmes L.B. Baldwin E.J. Smith C.R. Habecker E. Glassman L. Wong S.L. et al. (2008) Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70: 2152–2158.
42. Iqbal M.M. Rahman A. Husain Z. Mahmud S.Z. Ryan W.G. Feldman J.M. (2003) Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 15: 33–48.
43. Jablonowski K. Margolese H.C. Chouinard G. (2002) Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia. Can J Psychiatry 47: 975–976.
44. Jerling M. Lindstrom L. Bondesson U. Bertilsson L. (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 16: 368–374.
45. Kando J.C. Tohen M. Castillo J. Centorrino F. (1994) Concurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry 55: 255–257.
46. Kane J.M. (1998) Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 24: 62–67.
47. Karper L.P. Salloway S.P. Seibyl J.P. Krystal J.H. (1992) Prolonged postictal encephalopathy in two patients with clozapine-induced seizures. J Neuropsychiatry Clin Neurosci 4: 454–457.
48. Landry P. (2001) Gabapentin for clozapine-related seizures. Am J Psychiatry 158: 1930–1931.
49. Lane H.Y. Su K.P. Chang W.H. (1999) Seizures after discontinuation of low-dose lorazepam from originally seizure-free clozapine regimen: combined effects? J Clin Psychiatry 60: 408–409.
50. Langosch J.M. Trimble M.R. (2002) Epilepsy, psychosis and clozapine. Human Psychopharmacol Clin Exp 17: 115–119.
51. Lieberman J.A. Safferman A.Z. (1992) Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 63: 51–70.
52. Littrell K.H. Johnson C.G. Schultz R.E. (1995) The pharmacological management of clozapine-related seizures. J Psychosoc Nurs Ment Health Serv 33: 42–43.
53. Liukkonen J. Koponen H.J. Nousiainen U. (1992) Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment. Psychiatry Res 44: 107–112.
54. Longo L.P. Salzman C. (1995) Valproic acid effects on serum concentrations of clozapine and norclozapine. Am J Psychiatry 152: 650–650.
55. Lyall M. Pryor A. Murray K. (2007) Clozapine and speech dysfluency: two case reports. Psychiatr Bull 31: 16–18.
56. Malow B.A. Reese K.B. Sato S. Bogard P.J. Malhotra A.K. Su T.P. et al. (1994) Spectrum of EEG abnormalities during clozapine treatment. Electronencephlography Clin Neurophysiol 91: 205–211.
57. Matsuda K.T. Cho M.C. Lin K.M. Smith M.W. Young A.S. Adams J.A. (1996) Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients. Psychopharmacol Bull 32: 253–257.
58. McCarthy R.H. (1994) Seizures following smoking cessation in a clozapine responder. Pharmacopsychiatry 27: 210–211.
59. McElroy S.L. Keck P.E. Jr Pope H.G. Jr Hudson J.I. (1989) Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry 50(Suppl): 23–29.
60. Meltzer H.Y. Ranjan R. (1994) Valproic acid treatment of clozapine induced myoclonus. Am J Psychiatry 151: 1246–1247.
61. Miller D.D. (1991) Effect of phenytoin on plasma clozapine concentrations in two patients. J Clin Psychiatry 52: 23–25.
62. Miller D.D. (2000) Review and management of clozapine side effects. J Clin Psychiatry 61: 14–17.
63. Millson R.C. Owen J.A. Lorberg G.W. Tackaberry L. (2002) Topiramate for refractory schizophrenia. Am J Psychiatry 159: 675–675.
64. Murphy K. Delanty N. (2000) Drug induced seizures: general principles in assessment, management and prevention. CNS Drugs 14: 135–146.
65. Muzyk A. Gala G. Kahn D.A. (2010) Use of lamotrigine in a patient with a clozapine-related seizure. J Psychiatr Pract 16: 125–128.
66. National Institute for Clinical Excellence (2006) Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical Guidance 38, available at http://www.nice.org.uk.
67. Navarro V. Pons A. Romero A. Bernardo M. (2001) Topiramate for clozapine-induced seizures. Am J Psychiatry 158: 968–969.
68. Neufeld M.Y. Rabey J.M. Orlov E. Korcyzn A. (1996) Electroencephalographic findings with low-dose clozapine treatment in psychotic Parkinsonian patients. Clin Neuropharmacol 19: 81–86.
69. Ng C.H. Chong S.A. Lambert T. Fan A. Hackett L.P. Mahendran R. et al. (2005) An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels. Int Clin Psychopharmacol 20: 163–168.
70. Olesen O.V. Thomsen K. Jensen P.N. Wulff C.H. Rasmussen N.A. Refshammer C. et al. (1995) Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study. Psychopharmacology (Berl) 117: 371–378.
71. Pacia S.V. Devinsky O. (1994) Clozapine-related seizures: experience with 5,629 patients. Neurology 44: 2247–2249.
72. Palego L. Biondi L. Giannaccini G. Sarno N. Elmi S. Ciapparelli A. et al. (2002) Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables. Prog Neuropsychopharmacol Biol Psychiatry 26: 473–480.
73. Pantelis C. Adesanya A. (2001) Increased risk of neutropenia and agranulocytosis with sodium valproate used adjunctively with clozapine. Aust NZ J Psychiatry 35: 544–545.
74. Pfizer (2010) Summary of Product Characteristics. Epanutin Capsules 25, 50, 100 and 300 mg.
75. Ravasia S. Dickson R.A. (1998) Seizure on low-dose clozapine. Can J Psychiatry 43: 420–420.
76. Risby E.D. Epstein C.M. Jewart R.D. Nguyen B.V. Morgan W.N. Risch S.G. et al. (1995) Clozapine-induced EEG abnormalities and clinical response to clozapine. J Neuropsychiatry Clin Neurosci 7: 466–470.
77. Sajatovic M. Meltzer H.Y. (1996) Clozapine-induced myoclonus and generalized seizures. Biol Psychiatry 39: 367–370.
78. Schuld A. Kuhn M. Haack M. Kraus T. Hinxe-Selch D. Lechner C. et al. (2000) A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 33: 109–111.
79. Silvestri R.C. Bromfield E.B. Khoshbin S. (1998) Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients. Ann Pharmacother 32: 1147–1151.
80. Simpson G.M. Cooper T.A. (1978) Clozapine plasma levels and convulsions. Am J Psychiatry 135: 99–100.
81. Spina E. Avenoso A. Facciola G. Fabrazzo M. Monteleone P. Maj M. et al. (1998) Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia. Int Clin Psychopharmacol 13: 141–145.
82. Supprian T. Retz W. Deckert J. (1999) Clozapine-induced stuttering: epileptic brain activity? Am J Psychiatry 156: 1663–1664.
83. Taner E. Cosar B. Isik E. (1998) Clozapine-induced myoclonic seizures and valproic acid. Int J Psychiatry Clin Pract 2: 53–55.
84. Taylor D. Paton C. Kapur S. (2009a) The Maudsley Prescribing Guidelines, 10th edn, Informa Healthcare: London.
85. Taylor D.M. Douglas-Hall P. Olofinjana B. Whiskey E. Thomas A. (2009b) Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry 194: 165–167.
86. Thomas P. Lalaux N. Vaiva G. Goudemand M. (1994) Dose-dependent stuttering and dystonia in a patient taking clozapine. Am J Psychiatry 151: 1096a–1096a.
87. Tiihonen J. Nousianen U. Hakola P. Leinonen E. Tuunainen A. Mervaala E. et al. (1991) EEG abnormalities associated with clozapine treatment. Am J Psychiatry 148: 1406–1406.
88. Tiihonen J. Wahlbeck K. Kiviniemi V. (2009) The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. Schizophr Res 109: 10–14.
89. Toth P. Frankenburg F.R. (1994) Clozapine and seizures: a review. Can J Psychiatry 39: 236–238.
90. Tranulis C. Mouaffak F. Chouchana L. Stip E. Gourevitch R. Poirier M.F. et al. (2006) Somatic augmentation strategies in clozapine resistance—what facts? Clin Neuropharmacol 29: 34–44.
91. Treves I.A. Neufeld M.Y. (1996) EEG abnormalities in clozapine-treated schizophrenic patients. Eur Neuropsychopharmacol 6: 93–94.
92. Usiskin S.I. Nicolson R.O.B. Lenane M. Rapoport J.L. (2000) Gabapentin prophylaxis of clozapine-induced seizures. Am J Psychiatry 157: 482–483.
93. Wahlbeck K. Cheine M. Essali A. Adams C. (1999) Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 156: 990–999.
94. Welch J. Manschreck T. Redmond D. (1994) Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci 6: 250–256.
95. White D.M. Van Cott A.C. (2007) Clozapine (Clozaril®), seizures, and EEG abnormalities. Am J Electroneurod T 47: 190–197.
96. Wilson W.H. (1992) Clinical review of clozapine treatment in a state hospital. Hosp Community Psychiatry 43: 700–703.
97. Wilson W.H. Claussen A.M. (1994) Seizures associated with clozapine treatment in a state hospital. J Clin Psychiatry 55: 184–188.
98. Wong J. Delva N. (2007) Clozapine-induced seizures: recognition and treatment. Can J Psychiatry 52: 457–463.